Beam Therapeutics BEAM Holds Steady Above Support Potential for Upside Breakout Consumer Spending Resilient But Showing Signs of Strain Analysts Suggest ARCO Q1 2026 Earnings Strong EPS Beat Tempered by Market Skepticism Tribeca SPAC Targets AI and Clean Energy Sectors With 140 Million IPO